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Abstract: Genotype/phenotype association analyses (Treescan) with plasma lipid levels 
and functional site prediction methods (TreeSAAP and PolyPhen) were performed using 
sequence data for ANGPTL4 from 3,551 patients in the Dallas Heart Study. Biological 
assays of rare variants in phenotypic tails and results from a Treescan analysis were used as 
“known” variants to assess the site prediction abilities of PolyPhen and TreeSAAP. The 
E40K variant in European Americans and the R278Q variant in African Americans were 
significantly associated with multiple lipid phenotypes. Combining TreeSAAP and 
PolyPhen performed well to predict “known” functional variants while reducing noise from 
false positives. 
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1. Introduction 
No single method of analysis is sufficient to uncover all the information that can come from 
sequence data. What we can strive for is a set of methods that complement each other. For example, 
the fields of molecular evolution, phylogenetics, and population genetics have a long history of 
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sequence analysis [1,2]; however these methods do not typically use phenotype information. Many of 
these methods use knowledge about gene structure, amino acids, protein structure, and phylogenetics. 
We can borrow methods from these fields to identify polymorphic sites that may show evidence for 
selection or are likely to cause significant changes in expression or the nature of a protein. 
Romeo et al. [3,4] sequenced the exonic regions and boundaries for the ANGPTL4 (angiopoietin-
like protein 4) gene in patients from the Dallas Heart Study [5]. Results from analysis of these   
data [3] and subsequently in other ANGPTL genes [4] found that rare variants substantially contribute 
to variation in triglyceride levels. These groundbreaking papers substantiated these claims with 
biological assays showing that most rare variants in individuals in the tails of the triglyceride 
phenotypic distribution were functionally important by affecting secretion, expression, LDL inhibition, 
or loss of function. These results and data give us a rare opportunity to use “known” functional 
variants to assess the relative abilities of some site prediction methods such as PolyPhen [6] and 
TreeSAAP [7].  
Using this data, we performed a series of analyses using phylogenetic approaches. We used 
Treescanning [8] to identify variants associated with lipid phenotypes. We used PAML [9] and   
HyPhy [10] to describe selection patterns across the sequence. Finally, we used the known rare 
functional variants from Romeo et al. [3,4] and results for common variants from the Treescanning 
analyses to compare the relative specificity and sensitivity of PolyPhen, TreeSAAP, and various 
combinations of the two. 
2. Results and Discussion 
2.1. Phylogenetic and Treescanning Results 
2.1.1. Variants, Haplotypes, Networks, and Phylogenetic Trees 
Including a human reference sequence, there were 39 variants (27 missense, 11 synonymous) that 
produced 45 unique haplotypes. One missense mutation (G77R) from the previous study [3,4] was not 
included because the individual that harbored it had too much missing data to reliably infer its 
haplotypes. Four other variants (IVS3+1, K217X, FsK245, and FsS302) that were nonsense, frame 
shifts, or splicing mutations were not included in the selection analyses because the selection detection 
methods only consider amino acid replacements. 
The haplotype inferences were relatively easy because most individuals were heterozygous for only 
one site. Technically, the singleton variants cannot be definitively placed on a haplotype unless it is 
heterozygous for only that site. However, because Treescanning uses genotypes, these individuals will 
always be grouped in the heterozygous class when the two possible haplotype backgrounds are defined 
as different allele classes making the test invariant to the phasing of the singleton. Regardless, the 
treescanning results were the same when all singletons were excluded. As for the phylogenetic 
analyses, the short branch lengths suggest that they will have little impact on analysis. For TreeSAAP, 
the same substitution event will always be inferred as long they are seen as tips. 
The bootstrap analysis for the maximum likelihood (ML) tree revealed low resolution throughout 
the tree. The reason for such low resolution is the shortness of the branches. The haplotype network 
(Figure 1) illustrates this. Every single branch in the tree is only one step long, meaning that no Int. J. Mol. Sci. 2010, 11                 
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haplotype is more than one site different than its nearest neighbor in the network. Bootstrapping works 
by sampling sites with replacement, which means that a site on a particular branch will be excluded in 
some of the replicates. Only branches with many sites will show any confidence in a bootstrap 
analysis. However, in coalescent theory, these short connections are considered more likely. Statistical 
Parsimony [11] was designed to incorporate these criteria when the haplotypes are sampled within a 
population. Another feature of this network is that two haploypes (H1 and H2) represent 70% to 80% 
of each population (see Table 1). Almost every other haplotype is a single step from either of these  
two haplotypes. 
Figure 1. Phylogenetic network showing relationships among sampled haplotypes. Edges 
are labeled with the base or amino acid change and colored based on results from 
significant.PolyPhen and TreeSAAP results. The nodes are colored according to the known 
effect of the variant on the protein as determined by in vitro assays [3,4]. Yellow nodes 
indicate variants that prevent secretion; orange nodes indicate variants that cause a non-
functional protein to be secreted; white nodes were not tested in vitro; and gray is a 
synonymous substitution. 
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Table 1. Haplotype frequencies for the haplotypes in Figure 1 overall and each population. 
All = combined; EA = European American, AA = African American, MA = Mexican 
American.  
Haplotype All  EA  AA  MA  Other 
h1  0.51242 0.54341 0.47735 0.54052 0.68493 
h2  0.26020 0.28447 0.21706 0.34828 0.23288 
h12  0.06475 0.14402 0.02102 0.05862 0.06164 
h13 0.00015 0 0.00030 0  0 
h14  0.00015  0.00051  0 0 0 
h15  0.00030  0.00102  0 0 0 
h16  0.04186 0.00153 0.07936 0.00517 0.00685 
h17  0.00105 0.00255 0.00030 0.00086  0 
h18 0.00045  0.00102 0 0.00086 0 
h19 0.01220 0 0.02399 0  0 
h23  0.00015  0.00051  0 0 0 
h24  0.02997 0.00051 0.05774 0.00259  0 
h25 0.00015 0 0.00030 0  0 
h26 0.00030 0 0.00059 0  0 
h35 0.00045 0 0.00089 0  0 
h36 0.00015 0 0.00030 0  0 
h37 0.00211 0 0.00415 0  0 
h39 0.00015 0 0.00030 0  0 
h40  0.00015  0.00051  0 0 0 
h41 0.00015 0 0.00030 0  0 
h42  0.00015  0.00051  0 0 0 
h44 0.00015 0  0 0.00086 0 
h45  0.00015  0.00051  0 0 0 
h53 0.00030 0 0.00059 0  0 
h54  0.05285 0.00204 0.10127 0.00431  0 
h55 0.00015 0 0.00030 0  0 
h56 0.00015 0 0.00030 0  0 
h57  0.00015  0.00051  0 0 0 
h58  0.00467 0.00153 0.00651 0.00517  0 
h63 0.00015 0 0.00030 0  0 
h64 0.00015 0 0.00030 0  0 
h72 0.00015 0 0.00030 0  0 
h73  0.00015  0.00051  0 0 0 
h82  0.00015  0.00051  0 0 0 
h90 0.00015 0 0.00030 0  0 
h91 0.00030 0 0.00059 0  0 
h92  0.00030 0.00051 0.00000  0  0.00685 
h93 0.00060 0 0.00118 0  0 
h94 0.00015 0 0.00030 0  0 
h95 0.00407 0  0 0.02328 0 
h96  0.00708 0.01277 0.00296 0.00948 0.00685 
h97 0.00030 0 0.00059 0  0 
h98 0.00015 0 0.00030 0  0 
h102  0.00015  0.00051  0 0 0 Int. J. Mol. Sci. 2010, 11                 
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2.1.2. Treescanning Results 
As found by Romeo et al. [3], the branch carrying the E40K variant in the European American 
population was associated with various phenotypes. It was significant after correcting for multiple tests 
for triglycerides (multiple p = 0.0277), LDL (multiple p = 0.0141), and nominally for VLDL (nominal 
p = 0.0147, multiple p = 0.065). The full multivariate model for E40K is significant after multiple tests 
(multiple p = 0.0064). The univariate p-values are significant for triglycerides, LDL, and VLDL; 
however, the partial Wilk’s tests are only significant for LDL (p = 0.001) and nearly for triglycerides 
(p = 0.0556). This suggests that LDL probably contributes most to the association in the presence of 
the other variables followed by triglycerides while the univariate association of VLDL is probably 
accounted for correlations between the phenotypes. E40K was also nominally significant for 
triglycerides in the Mexican American populations even with a very small count of nine heterozygotes 
carrying the K variant (haplotype H96). It displayed the same protective effect of lower triglyceride 
levels as that found in the European Americans. No other variants within the European American 
population were significant in the second round of Treescanning. 
The branch carrying the R278Q variant was significant for HDL (multiple p = 0.0122) in the 
African American population. The Q allele (carried by haplotypes H23, H24, H63, and H64) is fairly 
common in African Americans (see Table 1) at about 5.8% but is very rare in all other populations. 
The full multivariate model was not significant after multiple test corrections but was nominally 
significant (nominal p = 0.0394). Triglycerides were nominally significant for the univariate test 
(nominal p = 0.0359) but this effect went away using the multivariate context of a partial Wilk’s test  
(p = 0.3814); however, HDL-c remained significant using the partial Wilk’s test (p = 0.0098). The QQ 
homozygote shows much higher adjusted HDL-c levels (67.88 mg/dL; n = 7) versus the RQ 
heterozygote (55.13 mg/dL; n = 156) and RR homozygote (52.06 mg/dL; n = 1263). This finding has 
not previously been reported, however the sample of the QQ homozygotes is relatively small (n = 7). 
The significance of R278Q still held up, even after conditioning for E40K in the African American 
population (multiple p = 0.0108). 
Talmud et al. [12] found mild evidence for an association with triglycerides with the T266M variant 
which is also the variant that separates the two major haplotypes (H1 and H2) in the network   
(see Figure 1). They found that this effect went away after conditioning upon the E40K variant. It is 
easy to see in Figure 1 how this variant could show an effect due to correlation with the E40K variant. 
Historically, the 40K mutation occurred on a 266M background resulting in linkage disequilibrium 
(LD) between the two variants. However, Talmud et al. [12] also found that T266M (but not E40K) 
was associated with postprandial triglyceride and glucose levels in a case/control study for individuals 
with a paternal history of myocardial infarction. In our study, T266M shows no association with any of 
the phenotypes and in any of our populations. At present, we do not have any data on postprandial 
stress to follow up their significant association with T266M. Int. J. Mol. Sci. 2010, 11                 
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2.2. Bioinformatics and Site Prediction Analysis Results 
2.2.1. PolyPhen and TreeSAAP Results 
PolyPhen identified eight residues as “probably damaging” and seven as “possibly damaging” for a 
total of 15, leaving 12 as benign (see Table 2). Of the eight residues that were either functional or 
significant, PolyPhen identified five as “probably damaging” and three as benign. TreeSAAP 
identified 10 at category 8, 5 with category 6 or 7, and 12 as nothing. Of the eight residues that were 
either functional or significant, TreeSAAP identified five at category 8, two with category 6 or 7, and 
one as nothing. While both methods predicted similar numbers of sites under selection, only nine sites 
were found in common between the methods while 10 sites were unique to a particular method. 
Table 2. PolyPhen and TreeSAAP results for each missense polymorphisms used in the 
study. Each rare variant is defined by which part of the triglyceride phenotype distribution 
it was found (H = high, M = Middle, L= Low) according to   
Romeo  et al. [3]. For the five common missense variants, Significant and NonSig 
(Nonsignificant) refers to phenotypic associations from the Treescan analyses. The 
Biological Assay column refers to assays in Table 3 of Romeo et al. [4]. A “-“ means no 
tests were performed. All significant PolyPhen predictions are in bold. All TreeSAAP 
properties considered significant with a score of 6 or more [13] are reported, all with an 
extreme value of 8 are in bold. The TreeSAAP property symbol key is provided below.  
Missense Phenotype Biological  PolyPhen  PolyPhen  TreeSAAP 
Variant Distribution  Assay  Score  Prediction  Property 
M-1-T M  -  NA  benign   
P-5-L M  -  NA  benign  αc, αn, K0, Hp  
E-40-K Significant  -  1.424  benign  pHi 
M-41-I NonSig  -  1.16  benign   
S-67-R M  -  1.563  possibly damaging   
R-72-L M  -  1.958  possibly damaging  H, Hnc, αn  
E-167-K L  LPL  Inhib  0.194  benign pHi 
P-174-S M  - 1.715  possibly damaging   
E-190-Q NonSig  -  0.243  benign   
E-196-K M  - 1.541  possibly damaging  pHi, El 
G-223-R L  Secretion  2.065  probably damaging  E’sm 
R-230-C M  - 2.792  probably damaging  pHi, E’sm, Et, Br, Ns, C 
F-237-V M  -  2.51  probably damaging   
P-251-T H  Nothing  1.781  possibly damaging   
T-266-M NonSig  -  0.783  benign  K0,  Ht 
R-278-Q Significant  -  0.644  benign  pHi 
V-291-M M  -  1.012  benign   
L-293-M M  -  1.236  benign  
E-296-V M  - 2.057  probably damaging  Ns, Pβ, Br, H, Ra  
P-307-S M  - 0.955  benign  αc 
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Table 2. Cont. 
Missense Phenotype Biological  PolyPhen  PolyPhen  TreeSAAP 
Variant Distribution  Assay  Score  Prediction  Property 
V-308-M M  -  1.199  benign   
R-336-C L  Secretion  2.255  probably damaging  Br, pHi, Et, Ns, C, Ca, Hnc 
D-338-E M  - 1.626  possibly damaging   
W-349-C L Secretion  3.677  probably damaging   
G-361-R L  Secretion  2.274  probably damaging 
Ca, E’sm, Mv, Mw, Hnc, V0, 
μ  
R-371-Q H Nothing  1.558  possibly damaging  pHi 
R-384-W L Secretion  2.304  probably damaging  Br, Ht 
TreeSAAP Property Key      
Alpha-helical tendency  Pα Molecular  weight  Mw 
Average # of surrounding residues  Ns  Normalized hydrophobicity  Hnc 
Beta-structure tendency  Pβ  Partial specific volume  V0 
Buriedness  Br  Power to be at the C-terminal  αc 
Composition  C  Power to be at the N-terminal  αn 
Compressibility K0  Refractive  index  μ 
Helical contact  Ca 
Short-range & medium-range nonbonded 
energy E’sm 
Hydropathy  H  Solvent accessible reduction ratio  Ra 
Isoelectric point  pHi  Surrounding hydrophobicity  Hp 
Long-range nonbonded energy  El  Thermodyn. transfer hydrophobicity  Ht 
Molecular volume  Mv  Total non-bonded energy  Et 
Figure 2. A schematic representation of ANGPTL4 coding region. The locations of variant 
sites are colored according to their affect on protein functionality as previously described 
[4]. Yellow sites prevent protein secretion, orange sites cause a non-functional protein to 
be secreted, and black sites were not tested in vitro. Amino acid sites identified by 
PolyPhen as “possibly damaging” are indicated in light red; “probably damaging” sites are 
shown in dark red. Radically changing (categories 6, 7, and 8) amino acid sites identified 
by TreeSAAP are shown in blue, with category 8 sites in dark blue. 
 
2.2.2. PAML and HyPhy results 
 
The PAML [9] M8 site prediction analysis did not find any sites under positive selection. A 
likelihood ratio test between the null model (M7) and the positive selection model (M8) did not 
support a class of sites under positive selection (ω > 1). The dual-rate random effects analysis Int. J. Mol. Sci. 2010, 11                 
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implemented in HyPhy [10] did not detect positive selection at the absolute threshold of 0.95. 
Purifying selection was only detected on sites where synonymous substitutions had occurred. We 
conclude that likelihood-based site prediction methods were ineffective at identifying functional 
variants for our data. Our findings correspond to other studies concluding that TreeSAAP is more 
sensitive than likelihood-based site prediction methods for identifying sites under adaptive   
selection [13,14]. 
However, likelihood-based methods proved to be useful in characterizing the selective constraint 
over distinct functional regions of ANGPTL4. We used the one ratio method (M0) implemented in 
PAML [9] to estimate the variation in functional constraint across the protein. The value of ω for the 
coiled-coil and fibrinogen-like domains is 1.057 and 0.386, respectively (see Figure 2). Using ω = 1 as 
the threshold between positive and negative selection, these results indicate that the coiled-coil domain 
is under nearly neutral selection, while the fibrinogen-like domain is under strong purifying selection. 
However, the metric of ω = 1 has been shown to underestimate the true amount of selective pressure 
on a protein region [15]. We estimated the value of ω to be 0.480 for the entire coding region. By 
using ω = 0.480 as a baseline, the coiled-coil domain appears to be under positive selection with 
respect to the rest of the gene, while the fibrinogen-like domain is under slightly negative (purifying) 
selection. These results suggest that the fibrinogen-like domains are under stronger functional 
constraint than the coiled-coil domain. 
The two domains of ANGPTL4 each have unique selective pressures that are driving the evolution 
of these domains. Post-translational processing cleaves the coiled-coil and fibrinogen-like domains. 
The coiled-coil domain is involved in the inhibition of LPL, which results in high triglyceride levels. 
The exact function of the fibrinogen-like domain is not well known. However, it is clear that the 
functional role performed by each domain is vastly different, and these differences in function would 
imply a specific set of evolutionary constraints. This is affirmed by the discrepancy between 
nonsynonymous and synonymous substitution rate ratios. It is interesting to observe that the five 
variants found to affect secretion from in vitro assays are all found in the fibrinogen-like domain 
(Figure 2). 
2.3. Comparison of PolyPhen and TreeSAAP 
While both PolyPhen and TreeSAAP identified similar numbers of mutations under selection, they 
differed considerably in terms of which mutations each identified (Table 3). Only two criteria show a 
significant difference between the Functional column and the “Middle or Not Sig” column: The 
TreeSAAP alone criteria or the Strict PolyPhen and Strict TreeSAAP criteria. Both share a very high 
sensitivity (87.5%) however the TreeSAAP alone criterion has a slightly higher false positive rate 
(41.2%) and also misclassifies the two high-tail nonfunctional variants. As expected, there is a trend of 
lower false positive (alpha) rates as we move to the stricter criteria, which is also accompanied by 
lower sensitivity (power). The Strict PolyPhen & Strict TreeSAAP criteria for significance have the 
highest specificity but also the lowest sensitivity. The Strict PolyPhen criteria may have the best 
combination of specificity and sensitivity. Int. J. Mol. Sci. 2010, 11                 
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Table 3. A comparison of results between PolyPhen, TreeSAAP, and their combinations 
with “known” data. Strict PolyPhen only counts “probably damaging” as significant while 
Strict TreeSAAP only counts category 8 as significant. P-values are from a two-tailed 
Fisher’s exact test of a 2 by 2 table comparing the “Functional or Significant column to the 
“Middle or Not Sig” column. Sensitivity, specificity, alpha, and beta levels are from this 
comparison. 
Significance 
Criteria 
   Functional  Tested  Middle 
p-val 
Odds 
Ratio 
Lower 
95 CI 
Upper 
95 CI 
  or Not  or 
  Significant Functional  Not  Sig 
PolyPhen  Significant 5  2 8  0.673  1.828  0.254  15.766 
 Not  Significant  3  0  9         
  Sensitivity  0.625  Specificity  0.529  alpha  0.471  beta  0.375 
TreeSAAP  Significant 7  2 7  0.042  9.130 0.859 
493.08
8 
 Not  Significant  1  0  10         
  Sensitivity  0.875  Specificity  0.588  alpha  0.412  beta  0.125 
Strict 
PolyPhen  Significant 5  0 3  0.061  7.012  0.846  77.356 
 Not  Significant  3  2  14         
  Sensitivity  0.625  Specificity  0.824  alpha  0.176  beta  0.375 
Strict 
TreeSAAP  Significant 5  0 5  0.194  3.762  0.505  34.675 
 Not  Significant  3  2  12         
  Sensitivity  0.625  Specificity  0.706  alpha  0.294  beta  0.375 
PolyPhen &  Significant 4  0 4  0.359  3.084  0.385  27.020 
TreeSAAP  Not Significant  4  2  13         
  Sensitivity  0.5  Specificity  0.765  alpha  0.235  beta  0.5 
Strict 
PolyPhen &  Significant 3  0 2  0.283  4.192  0.369  64.438 
Strict 
TreeSAAP  Not Significant  5  2  15         
  Sensitivity  0.375  Specificity  0.882  alpha  0.118  beta  0.625 
Strict 
PolyPhen OR  Significant 7  0 6  0.030 
11.52
6 1.077 
626.87
1 
Strict 
TreeSAAP  Not Significant  1  2  11         
  Sensitivity  0.875  Specificity  0.647  alpha  0.353  beta  0.125 
 
The purpose of these comparisons is to determine what is the best way to use these methods to 
define a subset of variants for biological assays and/or association analyses. For rare variants, 
individual association tests are meaningless; however, the phenotype data can be used in conjunction 
with these methods to narrow the likely candidates. In this case, most of the rare variants in the tails of 
triglyceride were functionally relevant according to biological assays. If these are a subset of variants 
sent for testing, both PolyPhen and TreeSAAP perform very well. TreeSAAP was able to identify five Int. J. Mol. Sci. 2010, 11                 
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of the six rare functional low-tail functional variants plus the two phenotypically associated variants 
while wrongly finding the two high-tail nonfunctional variants as significant. The two 
misclassifications disappear when moving to more strict criteria where both methods are identical. 
Both methods can be complementary because they give different information and have different 
aims. PolyPhen attempts to determine if a variant will damage a protein. TreeSAAP tries to identify 
mutations that are extremely out of the norm relative to the substitution patterns observed in the data 
for a specific biochemical property. The Strict PolyPhen and Strict TreeSAAP criteria suggest a 
variant has a high likelihood of importance by a least one method. In many cases, both methods give 
significant results because a variant is both damaging and it is a very extreme mutation according to 
the empirical data. It is not surprising that these two methods, which differ in their criteria for 
determining selection, differ in their outcomes. What is more surprising is that these methods that 
explore functional differences perform much better than the approaches (PAML and HyPhy) that 
simply look at dn/ds ratios. Clearly with these population genetic data, examining functional 
differences seems to provide greater insights into sites under natural selection. 
Based on these limited results, we recommend a combination of the two methods that look at 
functional variants in a population to be most desirable for choosing variants to create a priori tests. If 
the investment in following up with biological assays is very high then the Strict PolyPhen and Strict 
TreeSAAP criteria are a very strict filter that together have the lowest false positive rate. However, if 
the goal is to be inclusive, the Strict PolyPhen OR Strict TreeSAAP criterion was very sensitive while 
still lowering the false positive rate. 
3. Materials and Methods 
3.1. Study Description and Genetic Data 
The Dallas Heart Study is based on a population sample restricted to the Dallas area [5]. That is, 
individuals in the sample were ascertained randomly without reference to their phenotypic values or 
disease status. The samples sequenced for the ANGPTL4 gene contains 3,551 individuals   
(1,830 African Americans, 601 Hispanics, 1045 European Americans, and 75 other ethnicities). All 
exons from each gene were sequenced along with each intron/exon boundary. All sequencing was 
done at the Joint Genome Institute. Base calling, quality assessment and assembly were carried out 
using the Phred, Phrap, Polyphred, Consed software suite. All sequence variants identified were 
verified by manual inspection of the chromatograms, and missense mutations were confirmed by 
independent resequencing [3,16]. Five quantitative lipid measures related to heart disease were 
analyzed: Triglyceride, HDL, VLDL, LDL, and total cholesterol levels. 
3.2. Haplotype Networks and Phylogenetic Trees 
All exonic regions were aligned and haplotypes were statistically inferred from the genotype data, 
using PHASE 2.2 [17,18]. A haplotypes network was inferred using a modified version of TCS [19]. 
The haplotype tree showed no evidence for recombination [20]. Coalescent criteria [21,22] allowed for 
resolution of each loop by breaking the H16-H37, H12-H35, and H24-H25 branches in Figure 1. Int. J. Mol. Sci. 2010, 11                 
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Likelihood scores were calculated from the sequences for the unique haplotypes for 56 models of 
nucleotide evolution using PAUP* [23]. We determined the best-fit model of nucleotide evolution 
using a maximum likelihood ratio test implemented in Modeltest [24]. The HKY model [25] with a 
gamma distribution shape parameter of 0.0104 and a ti/tv ratio of 2.1982 was determined to be the best 
model given the data. A phylogenetic tree was estimated using the maximum likelihood criterion as 
implemented in the application PhyML [26]. Branch support for the tree was estimated using non-
parametric bootstrap sampling with 1,000 replicates. The ML tree was used for all analyses with 
TreeSAAP, PAML, and HyPhy. 
3.3. Genotype/Phenotype Association via Treescan 
After being adjusted for age, sex, and BMI, separate analyses for cholesterol, triglyceride, VLDL, 
LDL, and HDL levels were performed separately for African-Americans, Mexican-Americans, and 
European-Americans. Romeo et al. [3,4] found a number of rare variants that were functionally 
significant through biological assays. These known effects may group in ways that may affect 
associations at other common polymorphisms and branches in the network. Therefore, analyses were 
performed with and without the individuals harboring these variants. The estimated haplotype network 
was used for all Treescan [8,27,28] analyses. All treescanning analyses used genotypes as factors and 
only included genotypic classes with counts of five or more. All nominal and multiple-test corrected 
significance levels were obtained with 10,000 permutations. A permutation analog of the sequential 
step-down Bonferroni [29] was used for multiple test correction because it takes into account the 
correlation between tests. 
Because the five lipid phenotypes are biologically related to each other through hepatic and 
intestinal lipid metabolism, the results from the univariate Treescan analyses were tested in a 
multivariate one-way MANOVA model where each branch is jointly associated with triglyceride, 
HDL, VLDL, and LDL levels. Total cholesterol is excluded because it is a composite value of the 
other three. Significance levels will be derived in a similar fashion using the parametric p-value from 
the F transformation of the Wilk’s statistic. A partial Wilk's test can be used to test the effects of 
individual dependent (phenotypes) or independent variables while controlling for all the other 
variables in the model. The partial Wilk's test is a reduced versus full model approach. This 
conditional Wilk's statistic is calculated as follows [30]: 
Λ(yg y1,...,yg−1,yg+1,...,yp) =
Λp
Λp−1
  (1) 
where p is the number of phenotypes (dependent variables), yg is the phenotype of interest, Λp is the 
Wilk's statistic for the full model, and Λp−1 is the Wilk's statistic for a reduced model where yg is 
excluded. The resulting partial Wilk's statistic has an exact transformation to a partial F-statistic [30]: 
FvH ,vE−p+1 =
1− Λ
Λ
vE − p+1
vH
  (2) 
where Λ is the result of equation 1, p is the number of phenotypes, vE= N − k, vH= k − 1, N = number 
of individuals, and k = the number of factor levels in the one-way MANOVA. The partial Wilk's test 
measures the contribution of a single phenotype to the genotypic association in the presence of the Int. J. Mol. Sci. 2010, 11                 
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other phenotypes across all eigenvectors of the E
−1H matrix. Univariate F tests and partial Wilk's tests 
are calculated for each significant MANOVA result emerging from the initial Treescan. 
3.4. Bioinformatics, Site Prediction, and Selection Analyses 
3.4.1. PolyPhen Analysis 
Some nonsynonymous variants are benign and have little to no effect on protein function, while 
others can be extremely harmful and cripple the protein. A variant’s effect on protein function can be 
predicted using a multiple protein alignment to assign each variant a score of how harmful the variant 
will be to protein function via the software PolyPhen [6] (e.g., a PolyPhen score of 0 = benign and a 
score of 4 = probably damaging). Given the 3D protein structure for ANGPTL4 is unknown, PolyPhen 
predictions were based predominantly on an alignment of the homologous sequences obtained through 
a Blast search of the NRDB database. The 45 unique SNPs were submitted to and retrieved from the 
PolyPhen web server using batch submission and retrieval scripts. 
3.4.2. TreeSAAP Analysis 
Another approach to identifying sites that are subject to adaptive change is by analyzing the 
changes in physiochemical properties when a substitution occurs [31]. Substitutions are determined by 
reconstructing ancestral states given a phylogenetic tree. Operating under the assumption of 
completely random amino acid replacement, we can calculate the expected distribution of amino acid 
substitutions. The substitutions inferred from the ancestral states are then compared to the expected 
distribution to determine the significance of the observed changes via the software package TreeSAAP 
[7]. The ancestral character states used by TreeSAAP are estimated using BaseML, which is part of the 
PAML software package [9]. We analyzed 31 different physiochemical properties, with 8 magnitude 
categories. Substitutions with changes of magnitude 6, 7, and 8 are considered to be radically changing 
[13] and are used in this paper to indicate significant variants. 
3.4.3. Likelihood Selection Analysis 
We used several likelihood-based methods to estimate the influence of selection on ANGPTL4. 
Likelihood methods use a codon-based model [32] of evolution to estimate the nonsynonymous to 
synonymous rate ratio (ω). A value of ω > 1 is commonly thought to be an indicator of positive 
selection, ω = 1 is neutral evolution, and ω < 1 indicates purifying selection. We implemented the M8 
model in PAML [9], which allows the nonsynonymous rate to vary among sites, while the synonymous 
rate is assumed to be homogeneous. The dual-rate model, implemented in HyPhy [10], allows both the 
nonsynonymous and synonymous rates to vary between sites, which has been shown to have greater 
power when compared to models where only the nonsynonymous rate is allowed to vary [10]. Both 
methods were used to infer sites under selection across the entire coding sequence. 
Maximum likelihood was also used to estimate overall levels of selection in each of the protein 
domains and across the entire coding sequence. The coiled-coil and fibrinogen-like domains were 
separated, and ω was computed independently for each region. We used the one ratio (M0) model 
implemented in PAML [9], which assumes that ω is constant across all sites. Int. J. Mol. Sci. 2010, 11                 
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3.5. Comparison of TreeSAAP and PolyPhen 
Of the 27 nonsynonymous variants analyzed, the functional polymorphisms from the biological 
assays [3,4] and the significant variants from Treescan analyses will be treated as “known” functional 
variants from which to evaluate the results of TreeSAAP, PolyPhen and their combination. We will 
compare PolyPhen, Strict PolyPhen (only “probably damaging”), TreeSAAP, Strict TreeSAAP (only 
category 8), PolyPhen and TreeSAAP, and Strict PolyPhen and Strict TreeSAAP. The remaining 
variants of the 27 will be defined as nonfunctional. This is conservative because only variants in the 
tails of triglyceride were biologically tested. A two-tailed Fisher’s exact test was performed on a 2 by 
2 table with the rows being the results of the method and the columns being the “known” information 
on the variants. If a method performs well, we would expect that it should have a higher ratio in the 
functional column than nonfunctional column. Biological assays were performed on eight variants  
(2 in the high tail and 6 in the low). All six low-tail variants were shown to have some type of 
functional effect. The two high-tail variants did not show any functional evidence. These two variants 
were classified separately from the other variants. 
4. Conclusions 
From our study, we had three different types of analyses: Genotype/phenotype association 
(Treescan), overall selection analyses (PAML M0), and three site prediction methods (REL, PolyPhen 
and TreeSAAP). Besides PolyPhen, each type of analysis used some form of phylogenetic data, and 
each gave us additional insight. First, the Treescan analysis provided evidence for an association with 
HDL in African Americans with the R278Q variant. Second, the PAML M0 analysis demonstrated the 
coiled domain is under positive selection while the fibrinogen-like domain is under slightly negative 
selection. It is of interest that most of the rare functional variants are within the fibrinogen-like 
domain. Finally, the “known” functional variants were leveraged such that we could evaluate the 
relative merits of site prediction from PolyPhen and TreeSAAP. We concluded that a combination of 
both methods is likely the best approach to take. 
While no sequence analysis method is going to reveal everything about genotype/phenotype 
relations, we do have tools that can work together to give us greater insight and lead us towards 
productive paths. For association studies, sequence data can give us greater ability to estimate the 
phylogenetic relationships between haplotypes. This in turn leads to a greater context for which to 
direct and interpret statistical tests. For TreeSAAP, phylogenetic estimation allows for an empirical 
estimate of the distributions of different types of amino acid changes. From these distributions, we can 
make predictions about which particular changes are out of the ordinary and are more likely to have an 
impact on gene function and subsequently on the phenotypes that we are interested in. 
In future studies, these site prediction methods will be a first step to provide greater statistical 
power and impetus to invest in biological follow up. These methods create a priori hypotheses to be 
tested leading to greater statistical power with the reduced number of tests to correct for. These 
methods may also suggest the biological nature of sites predicted to have functional consequence. 
Many labs are currently embarking on whole exome sequencing. These methods will be useful as we 
try to comb through this mass of data to separate the functional from nonfunctional variants. Int. J. Mol. Sci. 2010, 11                 
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